VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma Lipids

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yang, Youfeng ^a   Cao, Zehong ^a   Tian, Ling ^b   Garvey, W Timothy ^b,c   Cheng, Guangjie ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHLORIDE; CHOLESTEROL; HYDROGEN PEROXIDE; LIPID; PEROXIDASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR PEROXIDASE 1; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; BINDING KINETICS; CELL STRAIN HEK293; CONTROLLED STUDY; EMULSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIPID OXIDATION; LIPID PEROXIDATION; LIPID TRANSPORT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL LINE; CHOLESTEROL; FOAM CELLS; HEK293 CELLS; HUMANS; HYDROGEN PEROXIDE; LIPIDS; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PEROXIDASES; RECOMBINANT PROTEINS; TRIGLYCERIDES;

EID: 84874350662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057571     Document Type: Article

References (55)

1. Choy PC, Siow YL, Mymin D, Karmin O, (2004) Lipids and atherosclerosis. Biochem Cell Biol 82: 212-224.
2. Cox RA, Garcia-Palmieri MR (1990) Cholesterol, Triglycerides, and Associated Lipoproteins. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston.
3. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH, (1984) Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25: 1277-1294.
4. Mahley RW, (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
5. Sing CF, Davignon J, (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285.
6. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
7. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
8. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R, (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140.
9. Reddick RL, Zhang SH, Maeda N, (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14: 141-147.
10. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, et al. (1995) Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 95: 469-476.
11. Hasty AH, Linton MF, Brandt SJ, Babaev VR, Gleaves LA, et al. (1999) Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation 99: 2571-2576.
12. Gaudreault N, Kumar N, Olivas VR, Eberle D, Rapp JH, et al. (2012) Macrophage-specific apoE gene repair reduces diet-induced hyperlipidemia and atherosclerosis in hypomorphic Apoe mice. PLoS One 7: e35816.
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL, (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924.
14. Luc G, Fruchart JC, (1991) Oxidation of lipoproteins and atherosclerosis. Am J Clin Nutr 53: 206S-209S.
15. Park JG, Oh GT, (2011) The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep 44: 497-505.
16. Podrez EA, Abu-Soud HM, Hazen SL, (2000) Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28: 1717-1725.
17. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, et al. (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158: 879-891.
18. Cheng G, Salerno JC, Cao Z, Pagano PJ, Lambeth JD, (2008) Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med 45: 1682-1694.
19. Cheng G, Li H, Cao Z, Qiu X, McCormick S, et al. (2011) Vascular peroxidase-1 is rapidly secreted, circulates in plasma, and supports dityrosine cross-linking reactions. Free Radic Biol Med 51: 1445-1453.
20. Li H, Cao Z, Moore DR, Jackson PL, Barnes S, et al. (2012) Microbicidal Activity of Vascular Peroxidase 1 in Human Plasma via Generation of Hypochlorous Acid. Infect Immun 80: 2528-2537.
21. Li H, Cao Z, Zhang G, Thannickal VJ, Cheng G, (2012) Vascular peroxidase 1 catalyzes the formation of hypohalous acids: characterization of its substrate specificity and enzymatic properties. Free Radic Biol Med 53: 1954-1959.
22. Havel RJ, Eder HA, Bragdon JH, (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
23. Chantepie S, Malle E, Sattler W, Chapman MJ, Kontush A, (2009) Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl. Arch Biochem Biophys 487: 28-35.
24. Hazell LJ, Stocker R, (1993) Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290 (Pt 1): 165-172.
25. Lambeth JD, (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189.
26. Tian L, Luo N, Klein RL, Chung BH, Garvey WT, et al. (2009) Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 202: 152-161.
27. Hasty AH, Linton MF, Swift LL, Fazio S, (1999) Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance. J Lipid Res 40: 1529-1538.
28. Babaev VR, Dergunov AD, Chenchik AA, Tararak EM, Yanushevskaya EV, et al. (1990) Localization of apolipoprotein E in normal and atherosclerotic human aorta. Atherosclerosis 85: 239-247.
29. O'Brien KD, Deeb SS, Ferguson M, McDonald TO, Allen MD, et al. (1994) Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol 144: 538-548.
30. Lassegue B, Griendling KK, (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30: 653-661.
31. Jolivalt C, Leininger-Muller B, Drozdz R, Naskalski JW, Siest G, (1996) Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci Lett 210: 61-64.
32. Jolivalt C, Leininger-Muller B, Bertrand P, Herber R, Christen Y, et al. (2000) Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 28: 129-140.
33. Panzenboeck U, Raitmayer S, Reicher H, Lindner H, Glatter O, et al. (1997) Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem 272: 29711-29720.
34. Marsche G, Hammer A, Oskolkova O, Kozarsky KF, Sattler W, et al. (2002) Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem 277: 32172-32179.
35. Malle E, Marsche G, Panzenboeck U, Sattler W, (2006) Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch Biochem Biophys 445: 245-255.
36. Jerlich A, Hammel M, Nigon F, Chapman MJ, Schaur RJ, (2000) Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl. Eur J Biochem 267: 4137-4143.
37. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, et al. (1995) Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270: 15747-15754.
38. Lin CY, Duan H, Mazzone T, (1999) Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res. 40: 1618-1627.
39. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, et al. (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 271: 30647-30655.
40. Singh U, Jialal I, (2006) Oxidative stress and atherosclerosis. Pathophysiology 13: 129-142.
41. Meir KS, Leitersdorf E, (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014.
42. Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley RW, et al. (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A 102: 18694-18699.
43. Saito H, Dhanasekaran P, Baldwin F, Weisgraber KH, Lund-Katz S, et al. (2001) Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. J Biol Chem 276: 40949-40954.
44. Sharp JS, Tomer KB, (2007) Analysis of the oxidative damage-induced conformational changes of apo- and holocalmodulin by dose-dependent protein oxidative surface mapping. Biophys J 92: 1682-1692.
45. Dornelles FN, Santos DS, Van Dyke TE, Calixto JB, Batista EL Jr, et al. (2009) In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw. J Pharmacol Exp Ther 330: 756-763.
46. Jovinge S, Ares MP, Kallin B, Nilsson J, (1996) Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16: 1573-1579.
47. Itabe H, Obama T, Kato R, (2011) The Dynamics of Oxidized LDL during Atherogenesis. J Lipids 2011: 418313.
48. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, et al. (1999) Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 180: 780-790.
49. Pennathur S, Heinecke JW, (2007) Oxidative stress and endothelial dysfunction in vascular disease. Curr Diab Rep 7: 257-264.
50. Szasz T, Thakali K, Fink GD, Watts SW, (2007) A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232: 27-37.
51. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, et al. (2000) Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 86: E85-90.
52. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, et al. (2008) Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol 52: 1803-1809.
53. Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB, (2002) PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 90: 1012-1019.
54. Shi R, Hu C, Yuan Q, Yang T, Peng J, et al. (2011) Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res 91: 27-36.
55. Bai YP, Hu CP, Yuan Q, Peng J, Shi RZ, et al. (2011) Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis. Free Radic Biol Med 51: 1492-1500.